Free Trial
NASDAQ:NAOV

Nanovibronix (NAOV) Stock Price, News & Analysis

Nanovibronix logo
$0.96 0.00 (-0.11%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$0.94 -0.01 (-1.53%)
As of 07/11/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nanovibronix Stock (NASDAQ:NAOV)

Key Stats

Today's Range
$0.92
$0.96
50-Day Range
$0.81
$4.42
52-Week Range
$0.67
$16.25
Volume
214,124 shs
Average Volume
1.83 million shs
Market Capitalization
$2.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nanovibronix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

NAOV MarketRank™: 

Nanovibronix scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Nanovibronix.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nanovibronix is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nanovibronix is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nanovibronix has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Nanovibronix's valuation and earnings.
  • Percentage of Shares Shorted

    44.80% of the float of Nanovibronix has been sold short.
  • Short Interest Ratio / Days to Cover

    Nanovibronix has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nanovibronix has recently increased by 40.77%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nanovibronix does not currently pay a dividend.

  • Dividend Growth

    Nanovibronix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    44.80% of the float of Nanovibronix has been sold short.
  • Short Interest Ratio / Days to Cover

    Nanovibronix has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nanovibronix has recently increased by 40.77%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nanovibronix has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Nanovibronix this week, compared to 0 articles on an average week.
  • Search Interest

    Only 5 people have searched for NAOV on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Nanovibronix to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nanovibronix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.30% of the stock of Nanovibronix is held by insiders.

  • Percentage Held by Institutions

    Only 16.39% of the stock of Nanovibronix is held by institutions.

  • Read more about Nanovibronix's insider trading history.
Receive NAOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanovibronix and its competitors with MarketBeat's FREE daily newsletter.

NAOV Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
NanoVibronix, Inc. (NAOV) - Yahoo Finance
NanoVibronix appoints new CEO after acquisition
See More Headlines

NAOV Stock Analysis - Frequently Asked Questions

Nanovibronix's stock was trading at $6.49 on January 1st, 2025. Since then, NAOV stock has decreased by 85.2% and is now trading at $0.9587.

Nanovibronix, Inc. (NASDAQ:NAOV) announced its earnings results on Tuesday, May, 20th. The company reported ($3.98) earnings per share for the quarter. The firm earned $1.02 million during the quarter. Nanovibronix had a negative trailing twelve-month return on equity of 54.73% and a negative net margin of 210.82%.

Nanovibronix shares reverse split on Friday, March 14th 2025.The 1-11 reverse split was announced on Wednesday, March 12th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 13th 2025. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nanovibronix investors own include Exela Technologies (XELA), Assertio (ASRT), Meta Platforms (META), T2 Biosystems (TTOO), NIO (NIO), Senseonics (SENS) and SNDL (SNDL).

Company Calendar

Last Earnings
5/20/2025
Today
7/12/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NAOV
CIK
1326706
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($13.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.70 million
Net Margins
-210.82%
Pretax Margin
-209.80%
Return on Equity
-54.73%
Return on Assets
-38.63%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.47
Quick Ratio
0.22

Sales & Book Value

Annual Sales
$2.56 million
Price / Sales
0.97
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.84 per share
Price / Book
0.52

Miscellaneous

Outstanding Shares
2,580,000
Free Float
2,422,000
Market Cap
$2.47 million
Optionable
Not Optionable
Beta
1.71
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:NAOV) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners